- Home
- YOUL vs XTNT Comparison
YOUL vs XTNT Comparison
Compare YOUL & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | YOUL | XTNT |
|---|---|---|
| Founded | N/A | N/A |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 107.2M | 86.2M |
| IPO Year | N/A | 2009 |
Fundamental Metrics
Financial Performance| Metric | YOUL | XTNT |
|---|---|---|
| Price | $1.13 | $0.57 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $1.50 |
| AVG Volume (30 Days) | 60.6K | ★ 133.8K |
| Earning Date | N/A | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.03 |
| Revenue | N/A | ★ $53,337,000.00 |
| Revenue This Year | N/A | $15.08 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $19.28 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.78 | $0.34 |
| 52 Week High | $4.40 | $0.95 |
Technical Indicators
Market Signals| Indicator | YOUL | XTNT |
|---|---|---|
| Relative Strength Index (RSI) | 42.06 | 37.95 |
| Support Level | $1.09 | $0.55 |
| Resistance Level | $1.95 | $0.66 |
| Average True Range (ATR) | 0.09 | 0.03 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 23.08 | 20.04 |
Price Performance
Historical ComparisonAbout YOUL Youlife Group Inc. American Depositary Shares
Youlife Group Inc is a blue-collar lifetime service provider with a nationwide network of 25 vocational schools under school management model and 25 curriculum development projects, covering a total of 37 cities or counties under 16 provinces of China.
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.